Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Chinese Medicine
Published in: Chinese Medicine 1/2020

Open Access 01-12-2020 | Pharmacokinetics | Correction

Correction to: Identifying the active components of Baihe–Zhimu decoction that ameliorate depressive disease by an effective integrated strategy: a systemic pharmacokinetics study combined with classical depression model tests

Authors: Ming Zhong, Xiaoting Tian, Shuoji Chen, Mingcang Chen, Ziqiong Guo, Minna Zhang, Gongpu Zheng, Zhixiong Li, Zhangpeng Shi, Guanghui Wang, Honggang Gao, Fang Liu, Chenggang Huang

Published in: Chinese Medicine | Issue 1/2020

Login to get access

Excerpt

In the original publication of this article [1], another affiliation (Affiliation 3: University of Chinese Academy of Sciences, Beijing 100049, People’s Republic of China.) for the author Ziqiong Guo is missing due to the carelessness during the author proof. In addition, in Affiliation 2 “Chinese Academy of Science” should be changed to “Chinese Academy of Sciences”. …
Literature
1.
Zhong M, Tian X, Chen S, Chen M, Guo Z, Zhang M, Zheng G, Li Z, Shi Z, Wang G, Gao H, Liu F, Huang C. Identifying the active components of Baihe–Zhimu decoction that ameliorate depressive disease by an effective integrated strategy: a systemic pharmacokinetics study combined with classical depression model tests. Chin Med. 2019;14:37.CrossRef
Metadata
Title
Correction to: Identifying the active components of Baihe–Zhimu decoction that ameliorate depressive disease by an effective integrated strategy: a systemic pharmacokinetics study combined with classical depression model tests
Authors
Ming Zhong
Xiaoting Tian
Shuoji Chen
Mingcang Chen
Ziqiong Guo
Minna Zhang
Gongpu Zheng
Zhixiong Li
Zhangpeng Shi
Guanghui Wang
Honggang Gao
Fang Liu
Chenggang Huang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Chinese Medicine / Issue 1/2020
Electronic ISSN: 1749-8546
DOI
https://doi.org/10.1186/s13020-020-00312-2

Other articles of this Issue 1/2020

Chinese Medicine 1/2020 Go to the issue

Research

The potential drug for treatment in pancreatic adenocarcinoma: a bioinformatical study based on distinct drug databases

Research

Ginsenoside Rg1 alleviates repeated alcohol exposure-induced psychomotor and cognitive deficits

Commentary

The potential insights of Traditional Chinese Medicine on treatment of COVID-19

Review

Potential therapeutic effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: a mini review

Review

Quality standard of traditional Chinese medicines: comparison between European Pharmacopoeia and Chinese Pharmacopoeia and recent advances

Research

Analysis of microRNA expression in peripheral blood monocytes of three Traditional Chinese Medicine (TCM) syndrome types in psoriasis patients